ACA
ASPN icon

Aptus Capital Advisors’s Aspen Aerogels ASPN Stock Holding History

Aptus Capital Advisors’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,537
Closed -$36K – 1789
2026
Q1 		$36K Buy
+10,537
New +$35.5K ﹤0.01% 1312

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Aptus Capital Advisors's ASPN Position: Q2 2026 in Review

Aptus Capital Advisors sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 10,537 shares — an estimated $36K sold.

Aptus Capital Advisors first reported a position in ASPN in Q1 2026 and held it in 1 quarter. The position peaked at $36K in Q1 2026. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Aptus Capital Advisors reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • Aptus Capital Advisors sold 10,537 Aspen Aerogels shares in Q2 2026, an estimated $36K.
  • Aptus Capital Advisors first reported a position in Aspen Aerogels in Q1 2026 and held it in 1 quarter.
  • Aptus Capital Advisors's Aspen Aerogels position peaked at $36K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.